The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma-Reference-Cited by-同舟云学术

The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma

Published:2017-03-09 Issue:5 Volume:98 Page:508-516
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Davies Joanna M.¹^ORCID,Osborne Thomas R.²,Edmonds Polly M.³,Schey Steve A.⁴,Devereux Steve⁴,Higginson Irene J.¹,Ramsenthaler Christina¹⁵

Affiliation:

1. Faculty of Life Sciences and Medicine; Department of Palliative Care, Policy and Rehabilitation; Cicely Saunders Institute; King's College London; London UK

2. St. Joseph's Hospice; London UK

3. Department of Palliative Care; King's College Hospital NHS Foundation Trust; London UK

4. Department of Haematological Medicine; King's College Hospital NHS Foundation Trust; London UK

5. Department of Palliative Medicine; Munich University Hospital; Munich Germany

Funder

King's College Hospital NHS Foundation Trust

Cicely Saunders International

National Institute for Health Research

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12864/fullpdf

Reference48 articles.

1. Steliarova-Foucher E O'Callaghan M Ferlay J European Cancer Observatory: Cancer Incidence, Mortality, Prevalence and Survival in Europe http://eco.iarc.fr

2. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network;Smith;Br J Cancer,2015

3. Non-Hodgkin lymphoma;Shankland;Lancet,2012

4. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource;Link;J Clin Oncol,2013

5. Follicular lymphoma: watch and wait is watch and worry;Ansell;Lancet Oncol,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geniposide improves depression by promoting the expression of synapse-related proteins through the Creb1/Six3os1 axis;Gene;2023-08

2. Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma care;BMC Cancer;2020-03-23

3. Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity;Frontiers in Pharmacology;2020-03-05

4. Priorities for Rural Lymphoma Survivors: A Qualitative Study;Clinical Lymphoma Myeloma and Leukemia;2020-01

5. Haematological malignancy: are we measuring what is important to patients? A systematic review of quality of life instruments;European Journal of Haematology;2018-12-16